Immuron (Warrant)

YTD

ALL

Why Robinhood?

You can watch IMRNW and buy or sell other stocks, options, and ETFs commission-free!

About IMRNW

Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. Its proprietary technology is based on polyclonal immunoglobulins derived from engineered hyper-immune bovine colostrum.

CEO

Steven Lydeamore, MBA

CEOSteven Lydeamore, MBA

Employees

—

Employees—

Headquarters

Carlton, Victoria (VIC)

HeadquartersCarlton, Victoria (VIC)

Founded

1994

Founded1994

Employees

—

Employees—

IMRNW Key Statistics

Market cap

—

Market cap—

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

—

Average volume—

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

—

52 Week high—

52 Week low

—

52 Week low—

IMRNW News

Yahoo Finance 5d

Immuron Director Resignation - Yahoo Finance

Immuron Limited MELBOURNE, Australia, May 03, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated bi...

TipRanks 5d

Immuron Director Files Final Interest Notice - TipRanks.com - TipRanks

Immuron Limited (AU:IMC) has released an update. Stephen Anastasiou, a director at Immuron Limited, has filed a Final Director’s Interest Notice, disclosing hi...